Tag: Sacubitril/valsartan

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Sacubitril/valsartan

Congestive Heart Failure Drugs Market Size, Share, Global Analysis, Restrains, Segments ...

Added to Collection on: 2021-04-02 12:11:15

Tags for this article:

Health sciences
Health
Aging-associated diseases
Heart diseases
Organ failure
ACE inhibitors
Heart failure
Novartis
Pharmaceutical industry
Hypertension
Beta blocker
Sacubitril/valsartan

Click the tags to see associated articles and topics

View Article Details
A Year Into the Pandemic, Science Carries on at ACC

Added to Collection on: 2021-05-13 20:57:07

Tags for this article:

Drugs
Medical specialties
Clinical medicine
Combination drugs
Cardiomyopathy
Heart diseases
Nonsteroidal anti-inflammatory drugs
Dapagliflozin
Heart failure with preserved ejection fraction
Sacubitril/valsartan
Cardiovascular disease
Hypertrophic cardiomyopathy

Click the tags to see associated articles and topics

View Article Details
ACC 2021 – Esbriet could Pirouette into heart failure

Added to Collection on: 2021-05-17 14:48:45

Tags for this article:

Drugs
Medical specialties
Clinical medicine
Anti-diabetic drugs
SGLT2 inhibitors
Heart diseases
Cardiomyopathy
Combination drugs
Heart failure with preserved ejection fraction
Sacubitril/valsartan
Heart failure
Ejection fraction
Esbriet

Click the tags to see associated articles and topics

View Article Details
Poor Choice of Stroke Patients for EVT; Sluggish Entresto Uptake; CBD for High BP ...

Added to Collection on: 2021-09-07 20:26:15

Tags for this article:

Medical specialties
Medicine
Clinical medicine
Interventional cardiology
Drug-eluting stent
Cardiology
Percutaneous coronary intervention
Restenosis
Sacubitril/valsartan
Heart failure

Click the tags to see associated articles and topics

View Article Details
Popular heart failure drug no better than older drug in sickest patients

Added to Collection on: 2021-11-04 06:16:13

Tags for this article:

Medicine
Medical specialties
Angiotensin II receptor antagonists
Chemical compounds
Antihypertensive agents
Carboxylic acids
Combination drugs
Cardiology
Sacubitril/valsartan
Valsartan
Angiotensin II receptor blocker
Sacubitril

Click the tags to see associated articles and topics

View Article Details
Top 5 Most-Read Non–COVID-19 Articles of 2021 - American Journal of Managed Care

Added to Collection on: 2021-12-23 14:11:03

Tags for this article:

Clinical medicine
Medicine
Medical specialties
Sleep disorders
Peptide hormones
Anti-diabetic drugs
Semaglutide
Diabetes
Medical equipment
Glucagon-like peptide-1
Obstructive sleep apnea
Sacubitril/valsartan

Click the tags to see associated articles and topics

View Article Details
AstraZeneca's dapagliflozin can “significantly” reduce risk of cardiovascular death in patients ...

Added to Collection on: 2022-05-23 11:32:50

Tags for this article:

Drugs
Anti-diabetic drugs
Medical specialties
Circulatory system
Heart diseases
Combination drugs
Glucosides
SGLT2 inhibitors
Dapagliflozin
Heart failure
Ejection fraction
Sacubitril/valsartan
AstraZeneca

Click the tags to see associated articles and topics

View Article Details
Top in cardiology: PFAS and hypertension; small risk with AstraZeneca COVID-19 vaccine

Added to Collection on: 2022-06-20 19:59:17

Tags for this article:

Pollution
Angiotensin II receptor antagonists
Drugs
Chemical compounds
Occupational safety and health
Per- and polyfluoroalkyl substances
Pollutants
Surfactants
Email
Oxford–AstraZeneca COVID-19 vaccine
Sacubitril/valsartan
Valsartan

Click the tags to see associated articles and topics

View Article Details
ESC22: AstraZeneca's Farxiga DELIVERs in heart failure - - Pharmaphorum

Added to Collection on: 2022-08-30 14:03:36

Tags for this article:

RTT
Cardiovascular system
Medical specialties
Chemical compounds
Heart diseases
Glucosides
SGLT2 inhibitors
Solute carrier family
Heart failure with preserved ejection fraction
Sacubitril/valsartan
Heart failure
Ejection fraction
AstraZeneca

Click the tags to see associated articles and topics

View Article Details
V-Wave Announces Late-Breaking Primary Results from Pivotal, Double-Blind, Randomized ...

Added to Collection on: 2024-04-06 19:58:17

Tags for this article:

Heart diseases
Cardiomyopathy
Heart failure with preserved ejection fraction
Medical equipment
Heart failure
Ejection fraction
Cerebral shunt
Clinical endpoint
Diabetic cardiomyopathy
Sacubitril/valsartan
V-Wave Inc.
United States

Click the tags to see associated articles and topics

View Article Details